4//SEC Filing
MiddleBrook Pharmaceuticals, Inc. 4
Accession 0001209191-10-056348
CIK 0001161924operating
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:17 PM ET
Size
12.2 KB
Accession
0001209191-10-056348
Insider Transaction Report
Form 4
EGI-Fund (08-10) Investors, L.L.C.
10% Owner
Transactions
- Other
Common Stock
2010-11-22−32,303,030→ 0 total - Other
Common Stock
2010-11-22+19,022,726→ 19,022,726 total
SZ INVESTMENTS LLC
10% Owner
Transactions
- Other
Common Stock
2010-11-22+19,022,726→ 19,022,726 total - Other
Common Stock
2010-11-22−32,303,030→ 0 total
EGI-MBRK, L.L.C.
10% Owner
Transactions
- Other
Common Stock
2010-11-22−32,303,030→ 0 total - Other
Common Stock
2010-11-22+19,022,726→ 19,022,726 total
CHAI TRUST CO LLC
10% Owner
Transactions
- Other
Common Stock
2010-11-22−32,303,030→ 0 total - Other
Common Stock
2010-11-22+19,022,726→ 19,022,726 total
Footnotes (2)
- [F1]EGI-MBRK, LLC ("Holder") distributed all 32,303,030 shares of the Common Stock of the Issuer held by Holder pro rata to its members, including 19,022,726 shares to EGI-Fund (08-10) Investors, L.L.C., which is the managing member of Holder.
- [F2]The Common Stock reported herein is owned directly by EGI-Fund (08-10) Investors, L.L.C. ("Fund 08-10") and indirectly by (a) SZ Investments, L.L.C. ("SZI"), which is the managing member of Fund 08-10; and (b) Chai Trust Company, LLC ("Trustee"), which is the trustee of the trusts (the "Trusts") which indirectly own SZI. The Trusts were established for the benefit of Samuel Zell and members of his family. Samuel Zell is neither an officer nor a director of the Trustee.
Documents
Issuer
MiddleBrook Pharmaceuticals, Inc.
CIK 0001161924
Entity typeoperating
Related Parties
1- filerCIK 0001161924
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:17 PM ET
- Size
- 12.2 KB